Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

被引:318
作者
Hofma, SH [1 ]
van der Giessen, WJ [1 ]
van Dalen, BM [1 ]
Lemos, PA [1 ]
McFadden, EP [1 ]
Sianos, G [1 ]
Ligthart, JMR [1 ]
van Essen, D [1 ]
de Feyter, PJ [1 ]
Serruys, PW [1 ]
机构
[1] Erasmus MC, Thoraxctr, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands
关键词
coronary stents; drugs; endothelium;
D O I
10.1093/eurheartj/ehi571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Endothelial dysfunction has been related both to progression of atherosclerotic disease and to future cardiovascular events. We assessed local epicardial endothelial function 6 months after sirolimus-eluting stent (SES) or bare metal stent (BS) implantation. Methods and results In 12 patients (seven SES, five BS), endothelium-dependent vasomotion of a coronary segment 15 mm in length, starting 2 mm distal to the stent, was assessed with quantitative coronary angiography immediately after the procedure and at 6 months follow-up, after intracoronary infusion of acetylcholine. Intravascular ultrasound (IVUS) was performed and coronary flow reserve (CFR) assessed in all patients. At follow-up significant vasoconstriction was seen in SES (median 32% diameter reduction from baseline) but not in BS (median 2% reduction) patients after acetylcholine infusion (P=0.03 for SES vs. BS); endothelium-independent vasodilatation to nitrates did not differ significantly between groups (20% SES, 5% BS, P=0.14). IVUS revealed no late unhealed dissections and CFR was comparable between groups (SES 3.1 vs. BS 3.2, n.s.). Conclusion SES implantation may have an adverse effect on local endothelium-dependent vasomotor responses compared with BS implantation at 6 months. Long-term clinical consequences of this observation are still unknown.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 17 条
[1]   Long-term endothelial dysfunction after coronary artery stenting [J].
Caramori, PRA ;
Lima, VC ;
Seidelin, PH ;
Newton, GE ;
Parker, JD ;
Adelman, AG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (06) :1675-1679
[2]   EFFECT OF RAPAMYCIN ON RAT AORTIC RING VASOMOTION [J].
CORBIN, F ;
BLAISE, GA ;
PARENT, M ;
CHEN, HF ;
DALOZE, PM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (05) :813-817
[3]   Local drug delivery via a coronary stent with programmable release pharmacokinetics [J].
Finkelstein, A ;
McClean, D ;
Kar, S ;
Takizawa, K ;
Varghese, K ;
Baek, N ;
Park, K ;
Fishbein, MC ;
Makkar, R ;
Litvack, F ;
Eigler, NL .
CIRCULATION, 2003, 107 (05) :777-784
[4]   Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries [J].
Gössl, M ;
Rosol, M ;
Malyar, NM ;
Fitzpatrick, LA ;
Beighley, PE ;
Zamir, M ;
Ritman, EL .
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2003, 272A (02) :526-537
[5]   Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [J].
Guba, M ;
von Breitenbuch, P ;
Steinbauer, M ;
Koehl, G ;
Flegel, S ;
Hornung, M ;
Bruns, CJ ;
Zuelke, C ;
Farkas, S ;
Anthuber, M ;
Jauch, KW ;
Geissler, EK .
NATURE MEDICINE, 2002, 8 (02) :128-135
[6]   Comparative study of cyclosporine and tacrolimus vs newer Immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function [J].
Jeanmart, H ;
Malo, O ;
Carrier, M ;
Nickner, C ;
Desjardins, N ;
Perrault, LP .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (09) :990-998
[7]   PARADOXICAL VASOCONSTRICTION INDUCED BY ACETYLCHOLINE IN ATHEROSCLEROTIC CORONARY-ARTERIES [J].
LUDMER, PL ;
SELWYN, AP ;
SHOOK, TL ;
WAYNE, RR ;
MUDGE, GH ;
ALEXANDER, RW ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (17) :1046-1051
[8]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[9]   Three-year follow-up of the RAVEL study:: A randomized study with the sirolimus-eluting Bx VELOCITY™ stent in the treatment of patients with de novo native coronary artery lesions [J].
Morice, MC ;
Serruys, P ;
Costantini, C ;
Wuelfert, E ;
Wijns, W ;
Fajadet, J ;
Colombo, A ;
Guagliumi, G ;
Molnar, F ;
Hayashi, EB ;
Sousa, JE ;
Perin, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :87A-88A
[10]   Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J].
Moses, JW ;
Leon, MB ;
Popma, JJ ;
Fitzgerald, PJ ;
Holmes, DR ;
O'Shaughnessy, C ;
Caputo, RP ;
Kereiakes, DJ ;
Williams, DO ;
Teirstein, PS ;
Jaeger, JL ;
Kuntz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1315-1323